CODX - Co-DiagnosticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $26.15 | Open | $26.52 |
| Volume | 1.47M | Market Cap | 758.37M |
| Yield | Last Dividend |
| Co-Diagnostics??? Covid-19 Test Scores A... | 08/05/20 |
| Co-Diagnostics??? (CODX) Covid-19 detector, the Logix Smart COVID-19 Test kit, has scored the green light from The Australian Therapeutic Goods Admini... | |
| Deadline Reminder: The Law Offices of Ho... | 06/26/20 |
| Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Co-Diagnostics, Inc. | |
| CODX INVESTOR ALERT: Kirby McInerney LLP... | 06/22/20 |
| NEW YORK--(BUSINESS WIRE)---- $CODX #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.... | |
| Glancy Prongay & Murray LLP Announces th... | 06/19/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Co-Dia... | |
| The Law Offices of Frank R. Cruz Announc... | 06/19/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... | |
| Law Offices of Howard G. Smith Announces... | 06/19/20 |
| Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Co-Diagnostics, Inc. securiti... | |
| The Law Offices of Frank R. Cruz Announc... | 06/18/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... | |
| Shareholder Alert: Robbins LLP Announces... | 06/18/20 |
| SAN DIEGO & SALT LAKE CITY--(BUSINESS WIRE)---- $CODX #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Co-Diagnosti... | |
| Glancy Prongay & Murray LLP, a National ... | 06/18/20 |
| LOS ANGELES--(BUSINESS WIRE)---- $CODX #fraud--Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of Co-Diagnostic... | |
| Has CoDiagnostics (CODX) Outpaced Other ... | 06/08/20 |
| Is (CODX) Outperforming Other Medical Stocks This Year? | |
| Can CoDiagnostics, Inc. (CODX) Run Highe... | 05/21/20 |
| CoDiagnostics, Inc. (CODX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revi... | |
| CoDiagnostics, Inc. (CODX) Moves to Stro... | 05/21/20 |
| CoDiagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This... | |
| Is CoDiagnostics (CODX) Outperforming Ot... | 05/21/20 |
| Is (CODX) Outperforming Other Medical Stocks This Year? | |
| Top Analyst Upgrades and Downgrades: Abb... | 05/20/20 |
| No summary available. | |
| Top Analyst Upgrades and Downgrades: App... | 05/18/20 |
| No summary available. | |
| The Daily Biotech Pulse: Co-Diagnostics ... | 05/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14) Allo... | |
| CoDiagnostics, Inc. (CODX) Reports Q1 Lo... | 05/14/20 |
| CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -25.00% and 40.82%, respectively, for the quarter ended March 2020. Do the numb... | |
| Why Co-Diagnostics Stock Is Jumping Toda... | 05/14/20 |
| Another COVID-19 test maker's pain appears to be behind Co-Diagnostics stock's gain. | |
| CoDiagnostics Inc (CODX) Gains As Market... | 05/12/20 |
| CoDiagnostics Inc (CODX) closed at $17.11 in the latest trading session, marking a +0.38% move from the prior day. | |
| Thinking about buying stock in Chembio D... | 04/20/20 |
| NEW YORK, April 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEMI, CODX, DD, F, and KHC. To see how InvestorsObser... | |
| Co-Diagnostics, Inc. Announces Expansion... | 04/20/20 |
| SALT LAKE CITY, April 20, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the Company), a molecular diagnostics company with a unique, paten... | |
| Thinking about buying stock in Bed Bath ... | 04/16/20 |
| NEW YORK, April 16, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBBY, CGEN, CODX, GE, and TRIP. To see how InvestorsO... | |
| Co-Diagnostics, Inc. COVID-19 Test Techn... | 04/16/20 |
| Co-Diagnostics, Inc. (Nasdaq: CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of molecular d... | |
| With FDA Approval in Place, Is Co-Diagno... | 04/14/20 |
| No summary available. | |
| What Is FDA Emergency Use Authorization? | 04/11/20 |
| As companies announce the marketing or development of diagnostic tests for the new coronavirus, they invariably reference an Emergency Use Authorizati... | |
| Co-Diagnostics COVID-19 Test Gets FDA Em... | 04/06/20 |
| Co-Diagnostics Inc (NASDAQ: CODX ) shares are getting boost on Monday. The positive reaction is in the wake of an announcement from the company that i... | |
| Co-Diagnostics, Inc Receives FDA Emergen... | 04/06/20 |
| Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic test... | |
| Co-Diagnostics Stock Is Not a Penny Stoc... | 03/31/20 |
| No summary available. | |
| Buy rating | 05/20/20 |
| Maxim Group upgrades from Hold to Buy rating and announces Price Target of $30.00 | |
| Buy rating | 05/18/20 |
| and raises Price Target from $20.00 to $35.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Short & Long | Short & Long | 88.00 % | Subscribe |
| Tech Trades | Tech Trades | 84.00 % | Follow |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Option short-term trading [Unusual] | Debashis K | 66.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
